Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes

NCT06985862 is registered in ClinicalTrials.gov with Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète as lead sponsor.

NCT NCT06985862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06985862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Artificial Intelligence Tools for the Detection of Stress Markers and Consideration of Stress States in the Monitoring of Subjects With Type 1 Diabetes
Lead sponsor
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
Phase
Not applicable
Overall status
Suspended
Start date
September 3, 2025
Completion date
December 31, 2026
Enrollment
35 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 1